In addition, glucagon-like peptide-1 has been shown to reduce plasma S-endoglin levels and oxidative stress in patients with T1DM, presumably due to its intracellular antioxidant activity (35). The gene discussed is GCG; the disease is type 1 diabetes mellitus.